| May 26, 2025 | Outcome Of The Order |
| May 26, 2025 | Declaration |
| May 21, 2025 | Outcome Of The Order |
| May 16, 2025 | Template Order |
| May 16, 2025 | Measures Decisionoutcome Notification |
| May 16, 2025 | Declaration |
| May 8, 2025 | Final Order |
| Apr 22, 2025 | Request To The Registrar For The Recording Of The Oral Hearing To Be Made Available |
| Apr 22, 2025 | Receipt |
| Apr 16, 2025 | Template Order |
| Apr 16, 2025 | Record |
| Apr 16, 2025 | Receipt |
| Apr 16, 2025 | Final Order Purposes |
| Apr 15, 2025 | Request Recording Oral Hearing |
| Apr 10, 2025 | Response Under Order April 2, |
| Apr 10, 2025 | Response Under App 15653 |
| Apr 9, 2025 | Receipt |
| Apr 8, 2025 | Generic Procedural Appplication |
| Apr 8, 2025 | Decision And Final Report Under Framework Agreement Part 5 |
| Apr 8, 2025 | Decision And Final Report Under Framework Agreement Part 4 |
| Apr 8, 2025 | Decision And Final Report Under Framework Agreement Part 3 |
| Apr 8, 2025 | Decision And Final Report Under Framework Agreement Part 2 |
| Apr 8, 2025 | Decision And Final Report Under Framework Agreement Part 1 |
| Apr 8, 2025 | Call For Proposals Under Framework Agreement (Reference:) Part 1 |
| Apr 8, 2025 | Call For Proposals Under Framework Agreement Part 4 |
| Apr 8, 2025 | Call For Proposals Under Framework Agreement Part 3 |
| Apr 8, 2025 | Call For Proposals Under Framework Agreement Part 2 |
| Apr 7, 2025 | Response Under Order Of April 2, |
| Apr 7, 2025 | Response Under Order App 15653. Of April 2, |
| Apr 7, 2025 | Receipt |
| Apr 7, 2025 | Exhibit 27 |
| Apr 7, 2025 | Exhibit 26 |
| Apr 7, 2025 | Exhibit 2 |
| Apr 7, 2025 | Exhibit 1 Permanent Certificate |
| Apr 7, 2025 | Exhibit 1 |
| Apr 7, 2025 | Applicant'S Note On Award Of Costs |
| Apr 4, 2025 | Bi Reply To Zentiva Evidence Submission |
| Apr 2, 2025 | Receipt |
| Apr 2, 2025 | Order |
| Mar 31, 2025 | Written Statement Ana Teixeira |
| Mar 31, 2025 | Written Statement Ana Lopes |
| Mar 31, 2025 | Receipt |
| Mar 31, 2025 | Order |
| Mar 31, 2025 | Exhibit 25 Defence Spms |
| Mar 31, 2025 | Exhibit 24 Defence Zentiva |
| Mar 31, 2025 | Exhibit 23 Article Prof. Marco Caldeira |
| Mar 31, 2025 | Exhibit 22 Zentiva Atos Societarios |
| Mar 31, 2025 | Exhibit 21 Declaration Manuela Kreuder |
| Mar 31, 2025 | Exhibit 20 Declaration Vanessa Jacinto |
| Mar 31, 2025 | Application Written |
| Mar 31, 2025 | Application For Written Witnesses Statements |
| Mar 28, 2025 | Generic Procedural Appplication |
| Mar 28, 2025 | Exhibit 1 Tpi Decision |
| Mar 24, 2025 | Receipt |
| Mar 21, 2025 | Rejoinder |
| Mar 21, 2025 | Exhibit 4 Order 1771 B 2016 |
| Mar 21, 2025 | Exhibit 3 Decree Law 19 2010 |
| Mar 21, 2025 | Exhibit 2 Order 55 2013 |
| Mar 21, 2025 | Exhibit 1 Proof Of Judicial Certificate |
| Mar 13, 2025 | Receipt |
| Mar 12, 2025 | Reply To The Objection |
| Mar 12, 2025 | Exhibit 19 |
| Mar 12, 2025 | Exhibit 18 |
| Mar 12, 2025 | Exhibit 17 |
| Mar 7, 2025 | Request Remit To Objection Filed 03.03 |
| Mar 7, 2025 | Acknowledgement Of Lodging |
| Mar 6, 2025 | Summon Oral Hearing |
| Mar 6, 2025 | Order |
| Mar 3, 2025 | Template Order |
| Mar 3, 2025 | Receipt |
| Mar 3, 2025 | Order 209.1(B) Rop |
| Mar 3, 2025 | Oral Hearing |
| Mar 3, 2025 | Objection Provisional Measures Application |
| Mar 3, 2025 | Exhibit 5 Clarification Boehringer Ingelheim Portugal 30.01 |
| Mar 3, 2025 | Exhibit 4 Specifications Framework Agreement No 491 Part 4 |
| Mar 3, 2025 | Exhibit 4 Specifications Framework Agreement No 491 Part 3 |
| Mar 3, 2025 | Exhibit 4 Specifications Framework Agreement No 491 Part 2 |
| Mar 3, 2025 | Exhibit 4 Specifications Framework Agreement No 491 Part 1 |
| Mar 3, 2025 | Exhibit 3 Framework Agreement Nintedanib Part 3 |
| Mar 3, 2025 | Exhibit 3 Framework Agreement Nintedanib Part 2 |
| Mar 3, 2025 | Exhibit 3 Framework Agreement Nintedanib Part 1 |
| Mar 3, 2025 | Exhibit 2 Case 57/25.1Yhlsb Part 3 |
| Mar 3, 2025 | Exhibit 2 Case 57/25.1Yhlsb Part 2 |
| Mar 3, 2025 | Exhibit 2 Case 57/25.1Yhlsb (I) |
| Mar 3, 2025 | Exhibit 1 Certificate Spc 679 |
| Feb 24, 2025 | Acknowledgement Of Access To Case |
| Feb 10, 2025 | Receipt Confirmation |
| Feb 10, 2025 | Notification Of Service |
| Jan 30, 2025 | Letter For Service |
| Jan 29, 2025 | Template Order |
| Jan 29, 2025 | Preliminary Order R |
| Jan 29, 2025 | Panel Appointment |
| Jan 23, 2025 | Response To The Request For Amendments |
| Jan 23, 2025 | Proof Of Payment Of Court Fees |
| Jan 23, 2025 | Formal Checks Notification Of Positive Outcome |
| Jan 23, 2025 | Exhibit 9 Zentiva Generics Mas: Infomed Extract (Pt And Eng) |
| Jan 23, 2025 | Exhibit 8 Decision Of China National Intellectual Property Administration |
| Jan 23, 2025 | Exhibit 7 Decision Of The Federal Court Of Canada |
| Jan 23, 2025 | Exhibit 6 EP1830843B1 Decision Of The Od Of The Epo |
| Jan 23, 2025 | Exhibit 5 Boehringer Ingelheim Pharma Gmbh & Co. Kg Authorization |
| Jan 23, 2025 | Exhibit 4 EP1830843B1 Epo Registrar And National Registrars |
| Jan 23, 2025 | Exhibit 3 EP1830843B1 |
| Jan 23, 2025 | Exhibit 2 Ofev Summary Of Product Characteristics And Package Leaflet |
| Jan 23, 2025 | Exhibit 1 Boehringer Ingelheim Pharma Gmbh & Co. Kg Authorized Boehringer Ingelheim International Gmbh To File To Proc |
| Jan 23, 2025 | Exhibit 16 Written Statement From Mariana Nascimento |
| Jan 23, 2025 | Exhibit 15 Iqvia Data |
| Jan 23, 2025 | Exhibit 14 EP1830843B1Opt Out And Withdrawal Of The Opt Out |
| Jan 23, 2025 | Exhibit 13 Notice No. (Pt And En) |
| Jan 23, 2025 | Exhibit 12 Zentiva Generics Smpc And Pl (Pt And En) |
| Jan 23, 2025 | Exhibit 11 Zentiva: Authorised And Registered Wholesale Distributor Of Medicines |
| Jan 23, 2025 | Exhibit 10 Zentiva Generics: Dcp Procedure |
| Jan 23, 2025 | Application For Provisional Measures |
| Jan 23, 2025 | Application For Measures Receipt |
| Jan 22, 2025 | Formal Checks Request For Correction |
| Jan 21, 2025 | Proof Of Payment Of Court Fees |
| Jan 21, 2025 | Exhibit 9 Zentiva Generics Mas: Infomed Extract (Pt And Eng) |
| Jan 21, 2025 | Exhibit 8 Decision Of China National Intellectual Property Administration |
| Jan 21, 2025 | Exhibit 7 Decision Of The Federal Court Of Canada |
| Jan 21, 2025 | Exhibit 6 EP1830843B1 Decision Of The Od Of The Epo |
| Jan 21, 2025 | Exhibit 5 Boehringer Ingelheim Pharma Gmbh & Co. Kg Authorization |
| Jan 21, 2025 | Exhibit 4 EP1830843B1 Epo Registrar And National Registrars |
| Jan 21, 2025 | Exhibit 3 EP1830843B1 |
| Jan 21, 2025 | Exhibit 2 Ofev Summary Of Product Characteristics And Package Leaflet |
| Jan 21, 2025 | Exhibit 1 Boehringer Ingelheim Pharma Gmbh & Co. Kg Authorized Boehringer Ingelheim International Gmbh To File To Proc |
| Jan 21, 2025 | Exhibit 16 Written Statement From Mariana Nascimento |
| Jan 21, 2025 | Exhibit 15 Iqvia Data |
| Jan 21, 2025 | Exhibit 14 EP1830843B1Opt Out And Withdrawal Of The Opt Out |
| Jan 21, 2025 | Exhibit 13 Notice No. (Pt And En) |
| Jan 21, 2025 | Exhibit 12 Zentiva Generics Smpc And Pl (Pt And En) |
| Jan 21, 2025 | Exhibit 11 Zentiva: Authorised And Registered Wholesale Distributor Of Medicines |
| Jan 21, 2025 | Exhibit 10 Zentiva Generics: Dcp Procedure |
| Jan 21, 2025 | Application For Provisional Measures |
| Jan 21, 2025 | Application For Measures Acknowledgement |